Cytel
Cytel Inc., a leading provider of advanced analytics and software solutions, is headquartered in Cambridge, Massachusetts, with significant operations across North America, Europe, and Asia. Founded in 1981, Cytel has established itself in the biostatistics and clinical trial sectors, offering innovative services that enhance the efficiency of drug development. The company is renowned for its unique offerings, including the East® software for adaptive trial design and its comprehensive statistical consulting services. Cytel's commitment to leveraging data-driven insights has positioned it as a trusted partner for pharmaceutical and biotechnology companies worldwide. With a strong focus on improving patient outcomes and accelerating time-to-market, Cytel continues to achieve notable milestones in the industry, solidifying its reputation as a pioneer in the realm of clinical research and biostatistics.
DitchCarbon Score
How does Cytel's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cytel's score of 36 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cytel's reported carbon emissions
In 2023, Cytel reported total greenhouse gas emissions of approximately 1.9 million tonnes CO2e. This figure includes 3,570 tonnes CO2e from Scope 1 emissions, 47,270 tonnes CO2e from Scope 2 emissions (market-based), and significant Scope 3 emissions, which totalled around 4.9 million tonnes CO2e. The Scope 3 emissions breakdown includes 219,700 tonnes CO2e from capital goods, 896,300 tonnes CO2e from business travel, 1,072,700 tonnes CO2e from employee commute, and 4.9 million tonnes CO2e from purchased goods and services. Cytel has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2022 as the base year. Additionally, the company targets a 51.6% reduction in Scope 3 emissions per million USD value added within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to global efforts to limit warming to 1.5°C.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 63,400 | 00,000 | 0,000 |
| Scope 2 | 95,600 | 000,000 | 00,000 |
| Scope 3 | 1,780,900 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cytel is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
